An App-Based Cognitive Behavioral Therapy Program for Cancer Patients with Sleep Problems: A Pilot Randomized Controlled Trial (Preprint)

2020 ◽  
Author(s):  
Kyong-Mee Chung ◽  
Yung Jae Suh ◽  
Siyung Chin ◽  
Eun-Seung Yu ◽  
Hyun Jeong Lee ◽  
...  
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Cancer Patients ◽  
Attentional Bias ◽  
Relaxation Training ◽  
Sleep Problems ◽  
Behavioral Therapy ◽  
Self Report ◽  
Cognitive Behavioral ◽  
Control Group ◽  
Therapy Program

UNSTRUCTURED Objective: To develop and evaluate an app-based cognitive behavioral therapy program for cancer patients with sleep problems. Method: Sixty participants who met the inclusion criteria were randomly assigned to the app-based cognitive behavioral therapy program (HARUToday Sleep) (N = 15), an app-based attentional control program (HARUCard Sleep) (N = 15), or a waitlist control group (N = 15). HARUToday Sleep consists of 48 sessions separated into five zones (psycho-education, behavioral activation, relaxation training, cognitive restructuring, and problem solving). Each participant was required to complete one 10- to 15-minute session per day on weekdays for 10 weeks. In the HARUCard Sleep, participants received one card per day, which provided information about cancer, hobbies, and activities. Participants were evaluated before and after the completion of the program using self-report questionnaires and a dot-probe computer task that measured attentional bias. Results: The intensity of sleep problems decreased significantly after the intervention for the HARUToday Sleep group compared to the other two groups, whereas there were no significant changes in the quality of life score and the attentional bias scores of the patients. Conclusion: The HARUToday Sleep app may be an effective intervention for reducing sleep problems in cancer patients.

scholarly journals Effectiveness of Cognitive Behavioral Therapy and Eye Movement Desensitization and Reprocessing in Child Victims of Domestic Violence

2019 ◽  
Author(s):  
Nasrin Jaberghaderi ◽  
Mansour Rezaei ◽  
Mitra Kolivand ◽  
Azita Shokoohi
Keyword(s):  
Domestic Violence ◽  
Cognitive Behavioral Therapy ◽  
Eye Movement ◽  
Behavioral Therapy ◽  
Self Report ◽  
Cognitive Behavioral ◽  
Individual Treatment ◽  
Control Group ◽  
Child Victims ◽  
Control Groups

Objective: This study was conducted to examine and compare the effectiveness of cognitive behavioral therapy (CBT) and eye movement desensitization and reprocessing (EMDR) in child victims of domestic violence (child physical abuse and/or witnessing parents’ conflicts). Method: A total of 139 girls and boys, aged 8-12 years, were randomly assigned into CBT (n = 40), EMDR (n = 40), or control groups (n=59). All children received up to 12 individual treatment sessions over 4–12 weeks. Blind assessment was done before and 2 weeks after the treatment and on a variety of teacher-parent-rated and self-report measures of posttraumatic symptomatology, depression, anxiety, and behavior problems. Results: CBT and EMDR were effective in ameliorating psychological sequelae of victims of domestic violence on the measured variables (p =.001). Comparison of the treatment and control groups suggested moderate to high practical significance in treatment groups vs controls. Conclusion: Both CBT and EMDR can help children to greatly recover from the outcomes of domestic violence in comparison with control group. Moreover, structured trauma treatments are strongly recommended and can be used for children

scholarly journals Effectiveness of Usual-Care Cognitive-Behavioral Therapy for Adolescents with Depressive Disorders Rated by Parents and Patients

2020 ◽  
Author(s):  
Daniel Walter ◽  
Jana Buschsieweke ◽  
Lydia Dachs ◽  
Hildegard Goletz ◽  
Anja Goertz-Dorten ◽  
...  
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Depressive Disorders ◽  
Behavioral Therapy ◽  
Routine Care ◽  
Self Report ◽  
Cognitive Behavioral ◽  
Effect Sizes ◽  
Control Group ◽  
Parent Rating ◽  
Wide Range

Abstract BackgroundDepressive disorders are common in adolescence and are associated with a wide range of negative long-term outcomes. Highly controlled randomized controlled trials (RCT) provide considerable evidence for the efficacy of cognitive-behavioral therapy (CBT) as a treatment for depression, but the effectiveness of CBT under routine care conditions remains unproven.MethodsIn the present observational study, the changes achieved through routine CBT in adolescents with depressive disorders treated in a university outpatient clinic were analyzed, and compared to a historical control group of adolescents with depressive disorders who had received treatment as usual. At the start and end of treatment (pre- and post-assessment), parent and self-ratings of the German versions of the Youth Self-Report (YSR), the Child Behavior Checklist (CBCL) and rating scales for depressive symptoms (FBB-DES, SBB-DES) were assessed. A total of 331 adolescents aged 11–18 years with complete data were assessed for the main analysis.ResultsThe analysis yielded small to large pre-post effect sizes (Cohen’s d) for the total sample (d = 0.33 to d = 0.82) and large effect sizes for adolescents who were rated in the clinical range on each (sub)scale at the start of treatment (d = 0.85 to d = 1.30). When comparing patients in the clinical range with historical controls, medium to large net effect sizes (d = 0.53 to d = 2.09) emerged for the total scores in self- and parent rating. However, a substantial proportion of the sample remained in the clinical range at the end of treatment.ConclusionsThese findings suggest that CBT is effective for adolescents with depressive disorders when administered under routine care conditions, but the results must be interpreted with caution due to the lack of a direct control condition.Trial registrationDRKS, DRKS00021518. Registered 27 April 2020 - Retrospectively registered, http://drks.de

scholarly journals Comparative Effectiveness of Cheonwangbosimdan (Tian Wang Bu Xin Dan) Versus Cognitive-Behavioral Therapy for Insomnia in Cancer Patients: A Randomized, Controlled, Open-Label, Parallel-Group, Pilot Trial

2020 ◽  
Vol 19 ◽  
pp. 153473542093564
Author(s):  
Sun-Young Moon ◽  
Ui Min Jerng ◽  
O-Jin Kwon ◽  
So-Young Jung ◽  
Jee Young Lee ◽  
...  
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Cancer Patients ◽  
Group Performance ◽  
Behavioral Therapy ◽  
Pilot Trial ◽  
Eastern Cooperative Oncology Group ◽  
Cognitive Behavioral ◽  
Control Group ◽  
Group Score ◽  
Significant Difference

Cancer patients have a 2 times higher prevalence of insomnia than healthy populations and cancer-related insomnia has received minimal attention while insomnia can aggravate the rehabilitation of cancer patients. Cheonwangbosimdan is a Korean herbal medicine generally used to relieve sleep deprivation, however, few studies presented the effects of Cheonwangbosimdan on cancer-related insomnia. The purpose of study is to examine the feasibility of Cheonwangbosimdan treatments for cancer patients. Twenty-two participants were allocated into a Cheonwangbosimdan or cognitive-behavioral therapy for insomnia (CBT-I) control group by equal number. The intervention group took Cheonwangbosimdan liquid once in a day and attend visits once a week for 4 weeks. The CBT-I group underwent individualized behavioral therapy 4 times in 4 weeks. The primary outcome is changes in the Insomnia Severity Index (ISI) from baseline to the end of the trial. Responses to the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), Zung Self-Rating Anxiety Scale (SAS), Brief Fatigue Inventory (BFI), Euroqol-5 Dimensions-5 Levels (EQ-5D-5L), and Eastern Cooperative Oncology Group Performance Status (ECOG-PS) were secondary outcomes used to evaluate the quality of sleep. Outcomes were measured at a follow-up visit (visit 5) in the fifth week of the trial. There is no difference between 2 groups, but both groups showed tendency to alleviate cancer insomnia symptoms. SAS-K showed significant difference between the 2 groups (P < .001), as treatment group score was highly lowered than control group score. The study can contribute to more attentive care for insomnia in cancer patients.

scholarly journals Effectiveness of Internet-Based Cognitive-Behavioral Therapy for Insomnia during Quarantine of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: A Controlled Trial

2021 ◽  
Author(s):  
Hossein Farrokhi ◽  
Behnaz Shid Anbarani ◽  
Seyyed Iman Seyyedzadeh ◽  
Atiyeh Taghavi Bojnordi ◽  
Mahnaz Amini
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Cognitive Behavioral Therapy ◽  
Relaxation Training ◽  
Behavioral Therapy ◽  
Controlled Trial ◽  
Drop Out ◽  
Cognitive Behavioral ◽  
Control Group ◽  
Insomnia Severity

Background and Objective: In the late 2019, an acute respiratory syndrome [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] resulted in a pandemic coronavirus disease (COVID-19). This study was designed to compare the efficacy of internet-based cognitive behavioral therapy for insomnia (ICBT-I) with online relaxation training for management of insomnia during SARS-CoV-2 pandemic. Materials and Methods: This controlled trial was conducted on adults (18-65 years) with the complaint of insomnia who called psychology call centers in Mashhad, Iran, from March to June 2020. Participants with insomnia symptoms starting after SARS-CoV-2 pandemic who had Insomnia Severity Index (ISI) scores of ≥ 15 were included in the study. Five weekly sessions of ICBT-I as the intervention were compared with 5 weekly online relaxation training sessions in the control group. ISI before and after 5 weeks of follow-up was compared in both groups. Results: From a total cohort of 144 subjects included in the study, 98 were excluded and the remainder were allocated to 23 cases and 23 control subjects. During follow-up period, 5 individuals (21.7%) dropped out in each group. The mean ISI scores improved after therapy (20.6 to 8.5 and 21.8 to 13.0 for intervention and control groups, respectively). Conclusion: ICBT-I significantly improved insomnia severity during home quarantine of SARS-CoV-2 pandemic. We suggest that ICBT-I could be an effective and feasible alternative in pandemic of an infectious disease. Clients accepted ICBT-I with a minor drop-out in our study.

RELATED FACTORS TO RELAPSE IN DEPRESSED PATIENTS AFTER COGNITIVE BEHAVIOURAL THERAPY DURING ONE YEAR PROSPECTIVE FOLLOW-UP

2011 ◽  
pp. 13-19
Author(s):  
Nhu Minh Hang Tran ◽  
Huu Cat Nguyen ◽  
Dang Doanh Nguyen ◽  
Van Luong Ngo ◽  
Vu Hoang Nguyen ◽  
...  
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Relapse Rate ◽  
Behavioral Therapy ◽  
Cognitive Behavioral ◽  
Control Group ◽  
Controlled Clinical Trial ◽  
Related Factors ◽  
Depressed Patients ◽  
One Year

Objectives: To determine factors impact on the relapse in depressed patients treated with Cognitive Behavioral Therapy (CBT) during one year follow-up. Materials and Methods: 80 depressed patients divided into two groups, group 1: included 40 patients treated with CBT; group 2: 40 patients on amitriptyline. Non-randomized controlled clinical trial, opened, longiditual and prospective research. Results and Conclusions: relapse rate after CBT during 1 year follow-up is 10% (compared to 25% in control group), related factors to relapse rate in depression after CBT are age and education. Shared predictors between 2 groups are severity and recurrence of depression. Key words: Depression, relapse, Cognitive Behavioral Therapy (CBT)

Sign in / Sign up

Export Citation Format

Share Document